TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
BiolacUm AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
394
|
601
|
834 |
| Financial expenses |
0
|
2,500
|
5,600 |
| Earnings before taxes |
2,160
|
-2,249
|
4,663 |
| EBITDA |
152
|
246
|
579 |
| Total assets |
7,385
|
5,286
|
7,558 |
| Current assets |
644
|
598
|
535 |
| Current liabilities |
62
|
49
|
19 |
| Equity capital |
7,154
|
5,030
|
7,336 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
96.9%
|
95.2%
|
97.1% |
| Turnover per employee |
394
|
601
|
834 |
| Profit as a percentage of turnover |
548.2%
|
-374.2%
|
559.1% |
| Return on assets (ROA) |
29.2%
|
4.7%
|
135.8% |
| Current ratio |
1038.7%
|
1220.4%
|
2815.8% |
| Return on equity (ROE) |
30.2%
|
-44.7%
|
63.6% |
| Change turnover |
-207
|
-233
|
149 |
| Change turnover % |
-34%
|
-28%
|
22% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.